The report entitled The Plasma Proteins Market in the Middle East 2013 provides sales in units and dollars of all the therapeutic plasma and recombinant proteins by company in Egypt, Iran, Israel, Jordan, Kuwait, Lebanon, Saudi Arabia, Turkey and the United Arab Emirates. This report is updated approximately every three years.

As in previous reports, the sales data in this region largely reflect the results of public tenders, and in a few countries sales on a generally modest private market. The report also analyses products distribution and pricing, blood and plasma collections, plasma fractionation, hemophilia care and new product introductions.

The report is delivered electronically (Excel and pdf files) and as a hard copy. Each country chapter covers the topics listed in the table of contents of a sample country chapter below.

For more information or to order this report, please contact
The Marketing Research Bureau at mrb_ibpn@earthlink.net, or +1 203 799-0298.


 

THE PLASMA PROTEINS MARKET IN THE MIDDLE EAST
2013

 

TABLE OF CONTENTS OF A SAMPLE COUNTRY CHAPTER

 

EXECUTIVE SUMMARY

HEALTH CARE ENVIRONMENT

BLOOD AND PLASMA COLLECTIONS

PLASMA FRACTIONATION

MARKET OVERVIEW

INTRAMUSCULAR IMMUNE GLOBULIN MARKET

Polyvalent Intramuscular & Sub-cutaneous Immune Globulin

Tetanus Immune Globulin

Rho(D) Immune Globulin

Rabies immune Globulin

Hepatitis B Immune Globulin

Other Hyperimmune Globulin

POLYVALENT INTRAVENOUS & SUBCUTANEOUS IMMUNE GLOBULIN (IVIG) MARKET

ALBUMIN MARKET

HEMOPHILIA CARE MARKET

         Demographic Data on Hemophilia

         Hemophilia Care Delivery

         Factor VIII

         Factor IX

         von Willebrand

         Inhibitors

OTHER PLASMA PRODUCTS MARKETS

         Alpha-1 Antitrypsin

         Antithrombin III

         Fibrin Adhesives

         Other Products

REGISTRATION AND REGULATIONS

PRICING AND DISTRIBUTION

MARKET TRENDS AND THREE-YEAR FORECAST

LIST OF MAJOR COMPANIES AND ORGANIZATIONS